Table 1.
General characteristics of outpatients stratified into 4 BP categories
| Parameters | Normotension | White‐coat HT | Masked HT | Sustained HT | P value |
|---|---|---|---|---|---|
| General characteristics | |||||
| Individuals (%) | 377 (17.1) | 351 (15.9) | 149 (6.7) | 1332 (60.3) | — |
| Female (%) | 241 (63.9) | 206 (58.7) | 61 (40.9) | 541 (40.6) | <.001 |
| Age (y) | 52.8 ± 15.9 | 52.1 ± 13.7 | 54.8 ± 14.6 | 52.2 ± 13.1 | .149 |
| BMI (kg/m2) | 25.6 ± 4.4 | 26.1 ± 4.3 | 26.4 ± 4.4 | 26.3 ± 4.3** | .039 |
| Risk factors and comorbidities | |||||
| Smoking (%) | 69 (18.3) | 66 (18.8) | 28 (18.7) | 245 (18.8) | .436 |
| Obesity (%) | 51 (13.5) | 61 (17.4) | 25 (16.8) | 209 (15.7) | .527 |
| Dyslipidaemia (%) | 24 (6.4) | 22 (6.3) | 11 (7.4) | 47 (3.5) | .013 |
| Diabetes (%) | 25 (6.6) | 17 (4.8) | 11 (7.4) | 60 (4.5) | .218 |
| Coronary artery disease (%) | 4 (1.1) | 1 (0.3) | 1 (0.7) | 4 (0.3) | .245 |
| Stroke/TIA (%) | 2 (0.5) | 2 (0.6) | 1 (0.7) | 8 (0.6) | .998 |
| Drug therapies | |||||
| Lipid Lowering drugs | 24 (6.4) | 22 (6.3) | 11 (7.4) | 47 (3.5) | .013 |
| Antiplatelet agents | 18 (4.8) | 22 (6.3) | 9 (6.0) | 44 (3.3) | .047 |
BMI, body mass index; IA, transient ischemic attack; THT, hypertension.
**P < .05 vs normotension.